New Delhi, March 27 (IANS) Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’, a report said on Friday.The company informed the court that it would propose a new brand name following the judge’s observation that the existing name could lead to confusion in a pharmaceutical setting.The dispute comes as India opens up to generic versions of semaglutide following patent expiry, trigg…
Latest Drugs Controller General of India News & Updates
New Delhi, March 17 (IANS) The Delhi High Court, on Tuesday, issued notice on a contempt petition alleging non-compliance with its earlier order directing Central Drugs Standard Control Organisation (CDSCO) to examine safety and regulatory concerns regarding the use of certain diabetes drugs for weight loss. A single-judge bench of Justice Sachin Datta sought responses from the Drugs Controller General of India (DCGI) and the Union Health Secretary Punya Salila Srivastava, and granted them four …